Loading clinical trials...
Loading clinical trials...
An Open Label, Randomized Phase II Study of BI 754091 Alone or in Combination With BI 836880 in Patients With Chemotherapy Resistant, Unresectable, Metastatic Squamous Cell Carcinoma of the Anal Canal
Conditions
Interventions
BI 754091
BI 836880
Locations
1
South Korea
Asan Medical Center
Seoul, South Korea
Start Date
September 14, 2020
Primary Completion Date
October 19, 2020
Completion Date
October 19, 2020
Last Updated
November 15, 2021
NCT04166318
NCT03712566
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions